Introduction: Psychotic depression (PD) is classified as a sybtype of severe depression in the current diagnostic manuals. Accordingly, it is a common conception that psychotic features in depression arise as a consequence of depressive severity. Objectives: To determine whether the severity of depression and psychosis correlate in accordance with the "severity-psychosis" hypothesis and to detect potential differences in clinical features of psychotic and non-psychotic depression (non-PD). Aims: We aimed to answer the following questions: • Does the clinical profile differ between patients with PD and non-PD? • Is the severity of depression and psychosis correlated in patients with depression? Methods: Quantitative analysis of Health of the Nation Outcome Scales (HoNOS) scores from all patients admitted to a Danish general psychiatric hospital between 2000 and 2010 due to a severe depressive episode. Results: A total of 357 patients with severe depression, of which 125 (35%) were of the psychotic subtype, formed the study sample. Mean HoNOS scores at admission differed significantly between patients with non-PD and PD on the items hallucinations and delusions (non-PD=0.33 vs. PD=1.37, p< 0.001), aggression (non-PD=0.20 vs. PD=0.36, p=0.044) and on the total score (non-PD=10.55 vs. PD=11.87, p=0.024). The HoNOS scores on the two items "depression" and " hallucinations and delusions" were very weakly correlated (Spearman coefficient=0.12). Conclusions: The results suggest that the severity of depression is unlikely to be the key determinant for the development of psychosis and supports the hypothesis that the psychotic-and non-psychotic subtypes of depression are in fact distinct clinical syndromes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.